MBOT
Microbot Medical Inc.
$1.82
0.00%
$122.2M
No data for this timeframe.
Vol
Market Cap$122.2M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (88%)
Inst. Holders33 funds
Inst. Value$25.4M
Inst. Activity5 buys / 1 sells
Reddit Sentiment55° Neutral
SEC Reports12
Press Releases1
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0000883975·Prev Close $1.82
Recent Activity
Jun 16, 2026
SEC
Microbot Medical entered into a vendor agreement with Lovell Government Services to sell its LIBERTY Endovascular Roboti
8-K — Impact 4/10
Jun 11, 2026
SEC
Three mega-passive institutional buyers (BlackRock, State Street, Fidelity) added Microbot Medical shares during Q3 2025
INST-CLUSTER — Impact 3/10
Jun 9, 2026
SEC
Microbot Medical announced its first Midwest account, a healthcare system in Michigan, for its LIBERTY Endovascular Robo
8-K — Impact 4/10
Jun 9, 2026
other
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® E
Apr 1, 2026
Insider
Wilson David James was granted 10,000 shares
Director
Apr 1, 2026
Insider
Wenderow Tal Baruch was granted 10,000 shares
Director
Apr 1, 2026
Insider
Laxminarain Prattipati was granted 10,000 shares
Director
Inst.
STIFEL FINANCIAL CORP — DOUBLED
573,075 shares ($1.4M)
Price Targets
$7.00
+284.6% upside
Strong Buy
Current $1.82
Low $4.00
Median $5.00
High $12.00
3 analysts
$4.00
$12.00
Analyst Ratings
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 3, 2026 | LUCID CAPITAL MARKETS | INITIATE | Buy |
| Apr 14, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Feb 10, 2026 | B. Riley Securities | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.08 ▼ -4.2% | $-0.09 — $-0.08 | 17% YoY | 3 |
| Next Q | $-0.08 | $-0.08 — $-0.08 | -14% YoY | 3 |
| Current FY | $-0.30 ▲ +6.3% | $-0.31 — $-0.29 | -3% YoY | 2 |
| Next FY | $-0.32 ▲ +3.0% | $-0.36 — $-0.28 | -7% YoY | 2 |
Latest Reports
NEUTRAL
8-K
4/10
Microbot Medical entered into a vendor agreement with Lovell Government Services to sell its LIBERTY Endovascular Roboti
Jun 16, 2026
NEUTRAL
INST-CLUSTER
3/10
Three mega-passive institutional buyers (BlackRock, State Street, Fidelity) added Microbot Medical shares during Q3 2025
Jun 11, 2026
NEUTRAL
Press
5/10
Microbot Medical announced the publication of its ACCESS-PVI multicenter feasibility study in the Journal of Vascular an
Mar 24, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $7.0M | — |
| CIBC Bancorp USA Inc. | $4.5M | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.2M | — |
| BlackRock, Inc. | $2.1M | ADD |
| DnB Asset Management AS | $1.6M | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 1, 2026 | Wilson David | A | $0.00 |
| Apr 1, 2026 | Wenderow Tal | A | $0.00 |
| Apr 1, 2026 | Laxminarain Prattipati | A | $0.00 |
| Apr 1, 2026 | Madden Martin | A | $0.00 |
| Apr 1, 2026 | Burell Scott | A | $0.00 |
Reddit Sentiment
55°
Neutral
Bearish
Neutral
Bullish
33 institutional holders with $25.4M total value (10,527,677 shares) as of 2026-Q1. Top holders: VANGUARD, CIBC, SUSQUEHANNA. Net buying activity: 5 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 2,909,525 | $7.0M | 27.6% | — |
| 2 | CIBC Bancorp USA Inc. | 1,870,000 | $4.5M | 17.8% | — |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 924,307 | $2.2M | 8.8% | — |
| 4 | BlackRock, Inc. | 857,398 | $2.1M | 8.1% | ADD +77.2% |
| 5 | DnB Asset Management AS | 677,498 | $1.6M | 6.4% | DOUBLED +178.1% |
| 6 | STIFEL FINANCIAL CORP | 573,075 | $1.4M | 5.4% | DOUBLED +115.4% |
| 7 | MARSHALL WACE, LLP | 481,045 | $1.2M | 4.6% | — |
| 8 | VANGUARD FIDUCIARY TRUST CO | 400,225 | $964.5K | 3.8% | — |
| 9 | GOLDMAN SACHS GROUP INC | 309,103 | $744.9K | 2.9% | — |
| 10 | STATE STREET CORP | 303,569 | $731.6K | 2.9% | ADD +46.5% |
| 11 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 204,100 | $491.9K | 1.9% | — |
| 12 | Russell Investments Group, Ltd. | 198,622 | $478.7K | 1.9% | — |
| 13 | Hudson Bay Capital Management LP | 121,082 | $291.8K | 1.2% | — |
| 14 | CITADEL ADVISORS LLC | 103,800 | $250.2K | 1.0% | — |
| 15 | OMERS ADMINISTRATION Corp | 85,500 | $206.1K | 0.8% | TRIM -41.4% |
| 16 | MORGAN STANLEY | 78,504 | $189.2K | 0.7% | DOUBLED +779.4% |
| 17 | BANK OF AMERICA CORP /DE/ | 75,799 | $182.7K | 0.7% | DOUBLED +1688.1% |
| 18 | BARCLAYS PLC | 53,166 | $128.1K | 0.5% | NEAR_EXIT -83.3% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 50,000 | $120.5K | 0.5% | — |
| 20 | GROUP ONE TRADING LLC | 46,563 | $112.2K | 0.4% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| STIFEL FINANCIAL CORP | DOUBLED | 265,990 | 573,075 | +115.4% | $1.4M | 2026-Q1 |
| STATE STREET CORP | ADD | 207,169 | 303,569 | +46.5% | $731.6K | 2026-Q1 |
| OMERS ADMINISTRATION Corp | TRIM | 146,000 | 85,500 | -41.4% | $206.1K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 4,239 | 75,799 | +1688.1% | $182.7K | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | ADD | 35,663 | 44,622 | +25.1% | $107.5K | 2026-Q1 |
| FMR LLC | DOUBLED | 1 | 4 | +300.0% | $10.00 | 2026-Q1 |
| VANGUARD GROUP INC | ADD | 2,343,561 | 3,329,721 | +42.1% | $6.7M | 2025-Q4 |
| BlackRock, Inc. | ADD | 490,189 | 868,652 | +77.2% | $1.7M | 2025-Q4 |
| DnB Asset Management AS | DOUBLED | 243,629 | 677,498 | +178.1% | $1.4M | 2025-Q4 |
| STIFEL FINANCIAL CORP | ADD | 157,492 | 265,990 | +68.9% | $532.0K | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 7,843 | 68,972 | +779.4% | $137.9K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 23,152 | 4,239 | -81.7% | $8.5K | 2025-Q4 |
| FMR LLC | NEAR_EXIT | 311 | 1 | -99.7% | $2.00 | 2025-Q4 |
| BlackRock, Inc. | ADD | 321,182 | 490,189 | +52.6% | $1.5M | 2025-Q3 |
| DnB Asset Management AS | ADD | 192,786 | 243,629 | +26.4% | $743.1K | 2025-Q3 |
| STATE STREET CORP | ADD | 138,520 | 208,469 | +50.5% | $635.8K | 2025-Q3 |
| UBS Group AG | DOUBLED | 41,528 | 202,845 | +388.5% | $618.7K | 2025-Q3 |
| STIFEL FINANCIAL CORP | DOUBLED | 16,104 | 157,492 | +878.0% | $480.4K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 5,867 | 23,152 | +294.6% | $70.6K | 2025-Q3 |
| MORGAN STANLEY | NEAR_EXIT | 157,770 | 7,843 | -95.0% | $23.9K | 2025-Q3 |
| FMR LLC | DOUBLED | 1 | 311 | +31000.0% | $948.00 | 2025-Q3 |
| BARCLAYS PLC | NEAR_EXIT | 6 | 1 | -83.3% | — | 2025-Q2 |
| VANGUARD GROUP INC | DOUBLED | 741,165 | 2,050,638 | +176.7% | $5.2M | 2025-Q2 |
| DnB Asset Management AS | ADD | 114,821 | 192,786 | +67.9% | $485.8K | 2025-Q2 |
| STIFEL FINANCIAL CORP | ADD | 10,659 | 16,104 | +51.1% | $40.6K | 2025-Q2 |
10 unique insiders with 10 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Wilson David James | Director | AWARD | 10,000 | — | — |
| Apr 1, 2026 | Wenderow Tal Baruch | Director | AWARD | 10,000 | — | — |
| Apr 1, 2026 | Laxminarain Prattipati | Director | AWARD | 10,000 | — | — |
| Apr 1, 2026 | Madden Martin J. | Director | AWARD | 10,000 | — | — |
| Apr 1, 2026 | Burell Scott R | Director | AWARD | 10,000 | — | — |
| Apr 1, 2026 | Stockburger Aileen Ptucha | Director | AWARD | 10,000 | — | — |
| Feb 18, 2026 | Gadot Harel | Chairman, President and CEO | AWARD | 480,000 | — | — |
| Feb 18, 2026 | Diaz-Cartelle Juan | Chief Medical Officer | AWARD | 105,000 | — | — |
| Feb 18, 2026 | Sharon Simon | General Manager, CTO | AWARD | 105,000 | — | — |
| Feb 18, 2026 | Vaknin Rachel | Chief Financial Officer | AWARD | 105,000 | — | — |
12 SEC filing reports analyzed. Sentiment: 3 bullish, 0 bearish, 0 mixed, 9 neutral. Avg impact: 4.3/10.
NEUTRAL
8-K
4/10
Microbot Medical entered into a vendor agreement with Lovell Government Services to sell its LIBERTY
Jun 16, 2026
NEUTRAL
INST-CLUSTER
3/10
Three mega-passive institutional buyers (BlackRock, State Street, Fidelity) added Microbot Medical s
Jun 11, 2026
NEUTRAL
8-K
4/10
Microbot Medical announced its first Midwest account, a healthcare system in Michigan, for its LIBER
Jun 9, 2026
NEUTRAL
8-K
4/10
Microbot Medical announced its first North Carolina-based healthcare system customer for the LIBERTY
Jun 2, 2026
BULLISH
8-K
6/10
Microbot Medical announced it received regulatory approval from the Israeli Ministry of Health's AMA
May 26, 2026
NEUTRAL
8-K
4/10
Microbot Medical filed an 8-K announcing a conference call on May 18, 2026, to address what it calls
May 15, 2026
BULLISH
8-K
5/10
Microbot Medical announced that it recorded revenue from its limited market release (LMR) of the LIB
May 14, 2026
NEUTRAL
8-K
3/10
Microbot Medical announced initial commercial adoption of its LIBERTY Endovascular Robotic System fo
May 5, 2026
NEUTRAL
8-K
3/10
Microbot Medical announced that updated occupational safety guidelines from SIR and CIRSE highlight
Apr 22, 2026
NEUTRAL
8-K
5/10
Microbot Medical announced the full market release of its LIBERTY Endovascular Robotic System and wi
Apr 14, 2026
BULLISH
8-K
7/10
Microbot Medical announced the successful limited market release and commencement of full market rel
Apr 13, 2026
NEUTRAL
8-K
3/10
Microbot Medical Inc. (MBOT) filed an 8-K to disclose compensation adjustments for three executive o
Feb 24, 2026
Current analyst consensus: Strong Buy (88% buy). Based on 8 analysts: 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$7.00 mean target
+284.6% upside
Strong Buy (1.00)
$4.00 Low
$12.00 High
| Metric | Value |
|---|---|
| Current Price | $1.82 |
| Target Low | $4.00 |
| Target Mean | $7.00 |
| Target Median | $5.00 |
| Target High | $12.00 |
| # Analysts | 3 |
| Recommendation | Strong Buy (1.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.08 | $-0.09 | $-0.08 | 16.7% | -4.2% | — | $0.0B | 0.0% | 3 |
| Next Q 2026-09-30 |
$-0.08 | $-0.08 | $-0.08 | -14.3% | +0.0% | — | $0.0B | 0.0% | 3 |
| Current FY 2026-12-31 |
$-0.30 | $-0.31 | $-0.29 | -3.5% | +6.3% | — | $0.0B | 0.0% | 2 |
| Next FY 2027-12-31 |
$-0.32 | $-0.36 | $-0.28 | -6.7% | +3.0% | 1↑ 0↓ | $0.0B | 207.2% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.083 | |
| 7d ago | $-0.090 | +0.007 |
| 30d ago | $-0.080 | -0.003 |
| 60d ago | $-0.080 | -0.003 |
| 90d ago | $-0.087 | +0.003 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 3, 2026 | LUCID CAPITAL MARKETS | INITIATE | — | Buy |
| Apr 14, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Feb 10, 2026 | B. Riley Securities | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Apr 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Mar 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
55°
Neutral
Bearish
Neutral
Bullish
6 mentions
3 bullish
2 bearish
6 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 16, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 16, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 14, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 13, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Feb 24, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 24, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
$MBOT - Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
▲ 1
💬 1
⚡ 0.5
$MBOT 10Q - Q1
▲ 1
💬 1
⚡ 0.5
MBOT adopted by top tier Florida Hospital
▲ 17
💬 6
⚡ 0.5
Jun 9, 2026
other
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
Jun 2, 2026
short_volume
Short Volume: MBOT — 58.0% short (0.4M / 0.8M)
Short: 436,704 | Exempt: 20,684 | TRF Vol: 753,269 | Short Ratio: 58.0% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: MBOT — 61.8% short (0.5M / 0.8M)
Short: 482,594 | Exempt: 12,061 | TRF Vol: 780,332 | Short Ratio: 61.8% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: MBOT — 55.6% short (1.0M / 1.7M)
Short: 962,638 | Exempt: 3,498 | TRF Vol: 1,730,827 | Short Ratio: 55.6% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: MBOT — 60.3% short (0.4M / 0.7M)
Short: 439,090 | Exempt: 8 | TRF Vol: 727,689 | Short Ratio: 60.3% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: MBOT — 55.2% short (0.5M / 1.0M)
Short: 541,565 | Exempt: 70,848 | TRF Vol: 981,766 | Short Ratio: 55.2% | Off-exchange volume (dark pool + OTC)
May 12, 2026
earnings_calendar
MBOT Q1 2026 Earnings Scheduled — 2026-05-12
May 6, 2026
short_volume
Short Volume: MBOT — 56.1% short (0.4M / 0.7M)
Short: 399,036 | Exempt: 5 | TRF Vol: 710,934 | Short Ratio: 56.1% | Off-exchange volume (dark pool + OTC)
May 1, 2026
short_volume
Short Volume: MBOT — 64.5% short (0.3M / 0.5M)
Short: 349,281 | Exempt: 235 | TRF Vol: 541,721 | Short Ratio: 64.5% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
other
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in EMEA
Apr 27, 2026
short_volume
Short Volume: MBOT — 58.5% short (0.4M / 0.6M)
Short: 359,867 | Exempt: 200 | TRF Vol: 615,160 | Short Ratio: 58.5% | Off-exchange volume (dark pool + OTC)
Apr 22, 2026
other
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
Apr 22, 2026
short_volume
Short Volume: MBOT — 60.5% short (0.5M / 0.9M)
Short: 526,497 | Exempt: 1,493 | TRF Vol: 870,744 | Short Ratio: 60.5% | Off-exchange volume (dark pool + OTC)
Apr 20, 2026
short_volume
Short Volume: MBOT — 62.7% short (0.7M / 1.1M)
Short: 683,131 | Exempt: 125 | TRF Vol: 1,088,688 | Short Ratio: 62.7% | Off-exchange volume (dark pool + OTC)
Apr 17, 2026
short_volume
Short Volume: MBOT — 56.7% short (0.6M / 1.0M)
Short: 580,159 | Exempt: 725 | TRF Vol: 1,023,014 | Short Ratio: 56.7% | Off-exchange volume (dark pool + OTC)